Cyberkinetics Neurotechnology Systems, Inc. is a medical device company focused on developing products to treat neurological diseases, and injuries involving the spinal cord and peripheral nerves. Specifically the company has (i) electrical stimulation technologies for nerve growth; and (ii) neural implants combined with signal processing apparatus that access and interact with the cerebral cortex and motor cortex at the level of individual cells. Our product pipeline currently includes: the Andara OFS Therapy for acute spinal cord injury which is designed to partially restore sensation and motor function in acute spinal cord injuries by stimulating nerve repair and is currently under review by the FDA for market clearance as a Humanitarian Device, the BrainGate System, currently in clinical evaluation, which is intended to allow a disabled person to control a computer and other devices, such as prosthetic limbs or a wheel chair, using thought alone, and the NeuroPort System, which is an FDA approved neurosurgical monitoring product. Our strategy is to leverage our proprietary technologies to establish ourselves as a leader in the field of neurotechnology. We also manufacture and market a line of neural recording arrays and data acquisition systems to researchers for use in animal studies.